Difficulty: Medium
Average Score: 88%
Practice
Which of the following drugs is 99% protein-bound in plasma?
Correct answer
D
Rationale
The correct answer is D) Diazepam. Diazepam is a benzodiazepine that is known to be highly protein-bound in plasma, with approximately 99% of the drug binding to plasma proteins. This high protein binding plays a significant role in the pharmacokinetics of diazepam, affecting its distribution, metabolism, and elimination in the body.
Gentamicin (Option A) is an antibiotic that is not known for its high protein binding in plasma. Theophylline (Option B) is a bronchodilator that has a moderate degree of protein binding, typically around 60-70%, but not as high as diazepam. Carbamazepine (Option C) is an anticonvulsant and mood stabilizer that has a protein binding of around 70-80%, lower than diazepam.
Understanding the protein binding characteristics of drugs is crucial in pharmacology as it influences their pharmacokinetic properties, such as their distribution, metabolism, and excretion in the body. Students need to grasp the concept of protein binding to comprehend how drugs interact in the bloodstream and tissues, impacting their effectiveness and potential for drug interactions and adverse effects. This question reinforces the importance of considering protein binding when prescribing or administering medications to patients.
Gentamicin (Option A) is an antibiotic that is not known for its high protein binding in plasma. Theophylline (Option B) is a bronchodilator that has a moderate degree of protein binding, typically around 60-70%, but not as high as diazepam. Carbamazepine (Option C) is an anticonvulsant and mood stabilizer that has a protein binding of around 70-80%, lower than diazepam.
Understanding the protein binding characteristics of drugs is crucial in pharmacology as it influences their pharmacokinetic properties, such as their distribution, metabolism, and excretion in the body. Students need to grasp the concept of protein binding to comprehend how drugs interact in the bloodstream and tissues, impacting their effectiveness and potential for drug interactions and adverse effects. This question reinforces the importance of considering protein binding when prescribing or administering medications to patients.